The interplay between the microbiome and colonic immune system in checkpoint inhibitor therapy.

Saved in:

Bibliographic Details
Title:	The interplay between the microbiome and colonic immune system in checkpoint inhibitor therapy.
Authors:	Dehinsilu J; The Wolfson Centre for Personalized Medicine and Medical Research Council (MRC) Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.; Diagnostics R&D, Medicines and Healthcare products Regulatory Agency, Potters Bar, United Kingdom., Sergaki C; Diagnostics R&D, Medicines and Healthcare products Regulatory Agency, Potters Bar, United Kingdom., Amos G; Diagnostics R&D, Medicines and Healthcare products Regulatory Agency, Potters Bar, United Kingdom., Fontana V; The Wolfson Centre for Personalized Medicine and Medical Research Council (MRC) Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom., Pirmohamed M; The Wolfson Centre for Personalized Medicine and Medical Research Council (MRC) Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
Source:	Frontiers in microbiomes [Front Microbiomes] 2023 Mar 03; Vol. 2, pp. 1061193. Date of Electronic Publication: 2023 Mar 03 (Print Publication: 2023).
Publication Type:	Journal Article; Review
Journal Info:	Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 9918540080706676 Publication Model: eCollection Cited Medium: Internet ISSN: 2813-4338 (Electronic) Linking ISSN: 28134338 NLM ISO Abbreviation: Front Microbiomes Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2813-4338
DOI:	10.3389/frmbi.2023.1061193